MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer

British Journal of Cancer

Volumn 99, Issue 2, 2008, Pages 350-356

  Suzuki, S ^a   Sasajima, K ^a   Sato, Y ^b   Watanabe, H ^a   Matsutani, T ^a   Iida, S ^a   Hosone, M ^a   Tsukui, T ^a   Maeda, S ^a   Shimizu, K ^a   Tajiri, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Active immunotherapy; Highly sensitive in situ hybridisation; Liver metastasis; MAGE A protein; MAGE A10 mRNA; Stomach cancer

Indexed keywords

COMPLEMENTARY RNA; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 10; MESSENGER RNA; ALPHA FETOPROTEIN; MAGE-A10 ANTIGEN; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RNA ANALYSIS; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SURVIVAL TIME; TUMOR GENE; BIOSYNTHESIS; CHEMISTRY; DISEASE COURSE; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; RNA PROBE; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RNA PROBES; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 48249149114     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604476     Document Type: Article

References (37)

1. Adachi Y, Tsuchihashi J, Shiraishi N, Yasuda K, Etoh T, Kitano S (2003) AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology 65: 95-101
2. Alves PMS, Lévy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JR, Halkic N, Speiser DE, Romero P, Lévy F (2007) Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 56: 839-847
3. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y (2005) High frequency of c-Met expression in gastric cancer producing alpha-fetoprotein. Oncology 59: 145-151
4. Ayyoub M, Rimoldi D, Guillaume P, Romero P, Cerottini JC, Valmori D, Speiser D (2003) Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanding during immune responses to antigen-expressing tumors in melanoma patients. Cancer Res 63: 5601-5606
5. Bricard G, Bouzourene H, Martinet O, Rimoldi D, Halkic N, Gillet M, Chaubert P, MacDonald HR, Romero P, Cerottini J, Speiser DE (2005) Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma. J Immunol 174: 1709- 1716
6. Chianese-Bullock KA, Pressley J, Garbee C, Hibbitts S, Murphy C, Yamshchikov G, Petroni GR, Bissonette EA, Neese PY, Grosh WW, Merrill P, Fink R, Woodson EM, Wiernasz CJ, Patterson JW, Slingluff CL (2005) MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of multipeptide vaccine for melanoma. J Immunol 174: 3080-3086
7. Cho YG, Son JH, Kim CJ, Lee YS, Kim SY, Nam SW, Lee JY, Park WS (2007) Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res 13: 4355-4359
8. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240: 808-816
9. Davis ID, Chen Q, Morris L, Quirk J, Stanley M, Tavarnesi ML, Parente P Cavicchiolo T, Hopkins W, Jackson H, Dimopolos N, Tai TY, MacGregor D, Browning J, Svobodova S, Caron D, Maraskovsky E, Old LJ, Chen W, Cebon J (2006) Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. J Immunother 29: 499-511
10. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethé B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369
11. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM (2005) Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241: 27- 39
12. 254-262: high activity-specific cytolytic T lymphocytes show superior antitumor activity. Cancer Res 61: 5850-5856
13. Dutoit V, Taub RN, Papadopoulos KP, Talbot S, Keohan ML, Brehm M, Gnjatic S, Harris PE, Bisikirska B, Guillaume P, Cerottini JC, Hesdorffer CS, Old LJ, Valmori D (2002) Multiepitope CD8+ T cell response to an NY-ESO-1 peptide vaccine results in imprecise tumor targeting. J Clin Invest 110: 1813-1822
14. Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC (2006) Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 120: 337-343
15. Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJG, Chen YT, Old LJ, Altorki NK (2005) Cancer-testis genes are coordinately expressed and are markers of poor outcome in nonsmall cell lung cancer. Clin Cancer Res 11: 8055-8062
16. Honda T, Tamura G, Waki T, Kawata S, Terashima M, Nishizuka S, Motoyama T (2004) Demethylation of MAGE promoters during gastric cancer progression. Br J Cancer 90: 838-843
17. Huang LQ, Brasseur F, Serrano A, Plaen ED, Bruggen P, Boon T, Pel AV (1999) Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J Immunol 162: 6849-6854
18. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, Akiyoshi T (1995) The expression of tumor-rejection antigen 'MAGE' genes in human gastric carcinoma. Gastroenterology 109: 1522-1525
19. Inoue M, Tsugane S (2005) Epidemiology of gastric cancer in Japan. Postgrad Med J 81: 419-424
20. Japanese Gastric Cancer Association (1998) Japanese Classification of Gastric Carcinoma - 2nd English edition. Gastric Cancer 1: 10-24
21. Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K, Okayasu I (2004) hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 17: 222-229
22. Jung EJ, Kim MA, Lee HS, Yang HK, Lee YM, Lee BL, Kim WH (2005) Expression of family A melanoma antigen in human gastric carcinoma. Anticancer Res 25: 2105-2111
23. Katano M, Nakamura M, Morisaki T, Fujimoto K (1997) Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. J Surg Oncol 64: 195-201
24. Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T, Itoh M (2001) Alpha-fetoprotein producing gastric cancer lacks transcription factor ATFB1. Oncogene 20: 869-873
25. Li J, Yang Y, Fujie T, Tanaka T, Mimori K, Haraguchi M, Ueo H, Mori M, Akiyoshi T (1997) Expression of the MAGE-gene family in human gastric carcinoma. Anticancer Res 17: 3559-3563
26. Peikert T, Specks U, Farver C, Erzurum SC, Comhair SA (2006) Melanoma antigen A4 is expressed in non-small cell lung cancer and promotes apoptosis. Cancer Res 66: 4693-4700
27. Peng JR, Chen HS, Mou DC, Cao J, Cong X, Qin LL, Wei L, Leng XS, Wang Y, Chen WF (2005) Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinomas and its correlation with clinical parameters. Cancer Lett 219: 223-323
28. Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC (1999) cDNA and protein characterization of human MAGE-10. Int J Cancer 82: 901- 907
29. Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC (2000) Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 86: 749-751
30. Sadanaga N, Nagashima H, Tahara K, Yoshikawa Y, Mori M (1999) The heterogeneous expression of MAGE-A3 protein: difference between primary lesions and metastatic lymph nodes in gastric carcinoma. Oncol Rep 6: 975-977
31. Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF (2006) Clinical outcome withlaparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243: 189-195
32. Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer. Ten-year results of the German gastric cancer study. Ann Surg 228: 449-461
33. Tanizaki Y, Sato Y, Oka H, Utsuki S, Kondo K, Miyajima Y, Nagashio R, Fujii K (2006) Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma. Pathol Int 56: 510-515
34. Wang Y, Wu XJ, Zhao AL, Yuan YH, Chen YT, Jungbluth AA, Gnjatic S, Santiago D, Ritter G, Chen WF, Old LJ, Ji JF (2004) Cancer/testis antigen expression and autologous humorial immunity to NY-ESO-1 in gastric cancer. Cancer Immun 4: 11
35. Yang B, O'Herrin S, Wu J, Reagan-Shaw S, Ma Y, Nihal M, Longley BJ (2007) Select cancer testis antigens of MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J Invest Dermatol 127: 267-275
36. Yoshida N, Abe H, Ohkuni T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, b Ikeda H, Nishimura T (2006) Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Int J Oncol 28: 1089-1098
37. Yoshikawa M, Takayasu N, Hashimoto A, Sato Y, Tamaki R, Tsukamoto H, Kobayashi H, Noda S (2007) The serine racemase mRNA is predominantly expressed in rat neurons. Arch Histol Cytol 70: 127-134